Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...

At an event held in the House of Lords on 5th November, The Trade Facilitation Commission released their detailed report and ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Stelia, the AI acceleration platform, and Polar, Europe's leader in AI-ready data centers, today announced a partnership set to redefine enterprise AI adoption. This collaboration integrates Stelia's ...

Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target ...

The drugmakers will explore the efficacy of Dato-DXd in combination with other drugs in PD-L1-expressing or EGFR-mutated NSCLC in these studies.

Speakers from Almirall, AstraZeneca, Bayer, BioNTech, Glenmark, and GSK share innovative approaches to drive commercial excellen ...

A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.

Oct 23 (Reuters) - Merck (MRK.N), opens new tab has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm ...

Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the ...

Last year, the company struck a $5.5 billion deal with Japan's Daiichi Sankyo to jointly develop three of its targeted cancer therapies, known as antibody drug conjugates, which work like "guided ...